Advancing the field of computational drug design using multicanonical molecular dynamics-based dynamic docking

Area of Science:

• Computational chemistry and molecular modeling.
• Drug discovery and design.
• Biophysics and structural biology.

Background:

• Predicting molecular binding is crucial for understanding biological processes and designing drugs.
• Traditional docking methods often struggle with flexible molecules and complex binding sites.
• Accurate simulation of binding/unbinding pathways and mechanisms remains a challenge.

Purpose of the Study:

• To introduce and validate a Multicanonical molecular dynamics (McMD)-based dynamic docking methodology.
• To demonstrate the application of McMD-based dynamic docking in computational drug design.
• To showcase the method's ability to predict native and alternative binding sites, including allosteric ones.

Main Methods:

• Development of a novel McMD-based dynamic docking methodology.
• Integration of the McMD algorithm with specialized toolsets for docking and analysis.
• Application of the method to three distinct case studies involving protein-ligand interactions.

Main Results:

• Successfully predicted the native binding configuration of an Hsp90 inhibitor.
• Identified binding modes for ligands interacting with Bcl-xL, including its cryptic binding site.
• Simulated the binding of a ligand to a membrane-embedded GPCR, revealing deep pocket interactions.

Conclusions:

• McMD-based dynamic docking provides an exhaustive sampling approach for accurate binding predictions.
• The methodology advances computational drug design by elucidating molecular binding mechanisms.
• This approach holds significant potential for addressing complex medical and biophysical challenges.